ALICA — Icape Holding SA Balance Sheet
0.000.00%
- €50.62m
- €89.76m
- €181.70m
- 49
- 72
- 11
- 36
Annual balance sheet for Icape Holding SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 23.7 | 26 | 28 | 32.8 | 26.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 29.2 | 46.3 | 45.6 | 39.7 | 45.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 59.5 | 88.8 | 88.3 | 87 | 84.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8.61 | 10.8 | 10.7 | 11.5 | 12.1 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 70.9 | 109 | 145 | 148 | 160 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 60.4 | 86.7 | 88.2 | 78.3 | 82 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 68.6 | 103 | 116 | 119 | 129 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 2.28 | 5.32 | 28.4 | 28.2 | 31 |
| Total Liabilities & Shareholders' Equity | 70.9 | 109 | 145 | 148 | 160 |
| Total Common Shares Outstanding |